Recruiting OBSERVATIONAL NCT06706856
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
Sponsor: GE Healthcare
Interventions
Blood draw MR exam Physical measurements Questionnaires US exam
Updated 2 times since 2024 Last updated: Jan 18, 2026 Started: Sep 23, 2024 Primary completion: Feb 28, 2029 Completion: Jun 30, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06706856, this observational or N/A phase trial focuses on MASLD and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease and remains actively recruiting participants. Sponsored by GE Healthcare, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
2 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Dec 2024 — Feb 2026 [monthly]
Recruiting
First recorded
Sep 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- GE Healthcare
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of California, San Diego
- Virginia Polytechnic Institute and State University
Data source: University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .